Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 766

1.

Self-administration of the synthetic cathinones 3,4-methylenedioxypyrovalerone (MDPV) and α-pyrrolidinopentiophenone (α-PVP) in rhesus monkeys.

Collins GT, Sulima A, Rice KC, France CP.

Psychopharmacology (Berl). 2019 Jul 26. doi: 10.1007/s00213-019-05339-4. [Epub ahead of print]

PMID:
31346629
2.

Effects of the synthetic psychedelic 2,5-dimethoxy-4-iodoamphetamine (DOI) on ethanol consumption and place conditioning in male mice.

Oppong-Damoah A, Curry KE, Blough BE, Rice KC, Murnane KS.

Psychopharmacology (Berl). 2019 Jul 15. doi: 10.1007/s00213-019-05328-7. [Epub ahead of print]

PMID:
31309240
3.

Methamphetamine Activates Toll-Like Receptor 4 to Induce Central Immune Signaling within the Ventral Tegmental Area and Contributes to Extracellular Dopamine Increase in the Nucleus Accumbens Shell.

Wang X, Northcutt AL, Cochran TA, Zhang X, Fabisiak TJ, Haas ME, Amat J, Li H, Rice KC, Maier SF, Bachtell RK, Hutchinson MR, Watkins LR.

ACS Chem Neurosci. 2019 Jul 17. doi: 10.1021/acschemneuro.9b00225. [Epub ahead of print]

PMID:
31282647
4.

Escalated Alcohol Self-Administration and Sensitivity to Yohimbine-Induced Reinstatement in Alcohol Preferring Rats: Potential Role of Neurokinin-1 Receptors in the Amygdala.

Nelson BS, Fulenwider HD, Nennig SE, Smith BM, Sequeira MK, Chimberoff SH, Richie CT, Cheng K, Rice KC, Harvey BK, Heilig M, Schank JR.

Neuroscience. 2019 Aug 10;413:77-85. doi: 10.1016/j.neuroscience.2019.06.023. Epub 2019 Jun 23.

PMID:
31242442
5.

Repeated administration of synthetic cathinone 3,4-methylenedioxypyrovalerone persistently increases impulsive choice in rats.

Hyatt WS, Berquist MD, Chitre NM, Russell LN, Rice KC, Murnane KS, Fantegrossi WE.

Behav Pharmacol. 2019 Jun 17. doi: 10.1097/FBP.0000000000000492. [Epub ahead of print]

PMID:
31211703
6.

M100907 and BD 1047 attenuate the acute toxic effects of methamphetamine.

Ray A, Canal CE, Ehlen JC, Rice KC, Murnane KS.

Neurotoxicology. 2019 Jun 1;74:91-99. doi: 10.1016/j.neuro.2019.05.011. [Epub ahead of print]

PMID:
31163210
7.

Stereochemistry and innate immune recognition: (+)-norbinaltorphimine targets myeloid differentiation protein 2 and inhibits toll-like receptor 4 signaling.

Zhang X, Peng Y, Grace PM, Metcalf MD, Kwilasz AJ, Wang Y, Zhang T, Wu S, Selfridge BR, Portoghese PS, Rice KC, Watkins LR, Hutchinson MR, Wang X.

FASEB J. 2019 Aug;33(8):9577-9587. doi: 10.1096/fj.201900173RRR. Epub 2019 Jun 4.

PMID:
31162938
8.

Metabolites of the ring-substituted stimulants MDMA, methylone and MDPV differentially affect human monoaminergic systems.

Luethi D, Kolaczynska KE, Walter M, Suzuki M, Rice KC, Blough BE, Hoener MC, Baumann MH, Liechti ME.

J Psychopharmacol. 2019 Jul;33(7):831-841. doi: 10.1177/0269881119844185. Epub 2019 Apr 30.

PMID:
31038382
9.

The adrenergic receptor antagonist carvedilol interacts with serotonin 2A receptors both in vitro and in vivo.

Murnane KS, Guner OF, Bowen JP, Rambacher KM, Moniri NH, Murphy TJ, Daphney CM, Oppong-Damoah A, Rice KC.

Pharmacol Biochem Behav. 2019 Jun;181:37-45. doi: 10.1016/j.pbb.2019.04.003. Epub 2019 Apr 15.

PMID:
30998954
10.

Sensitization to the prosocial effects of 3,4-methylenedioxymethamphetamine (MDMA).

Curry DW, Berro LF, Belkoff AR, Sulima A, Rice KC, Howell LL.

Neuropharmacology. 2019 Jun;151:13-20. doi: 10.1016/j.neuropharm.2019.03.017. Epub 2019 Mar 25.

PMID:
30922893
11.

Opioid-galanin receptor heteromers mediate the dopaminergic effects of opioids.

Cai NS, Quiroz C, Bonaventura J, Bonifazi A, Cole TO, Purks J, Billing AS, Massey E, Wagner M, Wish ED, Guitart X, Rea W, Lam S, Moreno E, Casadó-Anguera V, Greenblatt AD, Jacobson AE, Rice KC, Casadó V, Newman AH, Winkelman JW, Michaelides M, Weintraub E, Volkow ND, Belcher AM, Ferré S.

J Clin Invest. 2019 Mar 26;129(7):2730-2744. doi: 10.1172/JCI126912.

12.

The Supplement Adulterant β-Methylphenethylamine Increases Blood Pressure by Acting at Peripheral Norepinephrine Transporters.

Schindler CW, Thorndike EB, Rice KC, Partilla JS, Baumann MH.

J Pharmacol Exp Ther. 2019 Jun;369(3):328-336. doi: 10.1124/jpet.118.255976. Epub 2019 Mar 21.

13.

Effectiveness comparisons of G-protein biased and unbiased mu opioid receptor ligands in warm water tail-withdrawal and drug discrimination in male and female rats.

Schwienteck KL, Faunce KE, Rice KC, Obeng S, Zhang Y, Blough BE, Grim TW, Negus SS, Banks ML.

Neuropharmacology. 2019 May 15;150:200-209. doi: 10.1016/j.neuropharm.2019.01.020. Epub 2019 Jan 18.

PMID:
30660628
14.

Role of mu-opioid agonist efficacy on antinociceptive interactions between mu agonists and the nociceptin opioid peptide agonist Ro 64-6198 in rhesus monkeys.

Cornelissen JC, Steele FF, Tenney RD, Obeng S, Rice KC, Zhang Y, Banks ML.

Eur J Pharmacol. 2019 Feb 5;844:175-182. doi: 10.1016/j.ejphar.2018.12.021. Epub 2018 Dec 12.

PMID:
30552903
15.

Regulation of cid and lrg expression by CcpA in Streptococcus mutans.

Kim HM, Waters A, Turner ME, Rice KC, Ahn SJ.

Microbiology. 2019 Jan;165(1):113-123. doi: 10.1099/mic.0.000744. Epub 2018 Nov 26.

16.

Effects of acute treatments with the serotonin 2A antagonist M100907 alone or in combination with the serotonin 2C agonist WAY163909 on methamphetamine self-administration in rhesus monkeys.

Odabas-Geldiay M, Shields H, Berro LF, Rice KC, Howell LL.

Drug Alcohol Depend. 2019 Jan 1;194:252-256. doi: 10.1016/j.drugalcdep.2018.10.018. Epub 2018 Nov 13.

PMID:
30469095
17.

Interplay of Nitric Oxide Synthase (NOS) and SrrAB in Modulation of Staphylococcus aureus Metabolism and Virulence.

James KL, Mogen AB, Brandwein JN, Orsini SS, Ridder MJ, Markiewicz MA, Bose JL, Rice KC.

Infect Immun. 2019 Jan 24;87(2). pii: e00570-18. doi: 10.1128/IAI.00570-18. Print 2019 Feb.

18.

The 5-HT2A Receptor (5-HT2AR) Regulates Impulsive Action and Cocaine Cue Reactivity in Male Sprague-Dawley Rats.

Sholler DJ, Stutz SJ, Fox RG, Boone EL, Wang Q, Rice KC, Moeller FG, Anastasio NC, Cunningham KA.

J Pharmacol Exp Ther. 2019 Jan;368(1):41-49. doi: 10.1124/jpet.118.251199. Epub 2018 Oct 29.

19.

Preclinical Evaluation of the First Adenosine A1 Receptor Partial Agonist Radioligand for Positron Emission Tomography Imaging.

Guo M, Gao ZG, Tyler R, Stodden T, Li Y, Ramsey J, Zhao WJ, Wang GJ, Wiers CE, Fowler JS, Rice KC, Jacobson KA, Kim SW, Volkow ND.

J Med Chem. 2018 Nov 21;61(22):9966-9975. doi: 10.1021/acs.jmedchem.8b01009. Epub 2018 Nov 13.

PMID:
30359014
20.

Cocaine reward is reduced by decreased expression of receptor-type protein tyrosine phosphatase D (PTPRD) and by a novel PTPRD antagonist.

Uhl GR, Martinez MJ, Paik P, Sulima A, Bi GH, Iyer MR, Gardner E, Rice KC, Xi ZX.

Proc Natl Acad Sci U S A. 2018 Nov 6;115(45):11597-11602. doi: 10.1073/pnas.1720446115. Epub 2018 Oct 22.

21.

Stereoselective effects of the second-generation synthetic cathinone α-pyrrolidinopentiophenone (α-PVP): assessments of conditioned taste avoidance in rats.

Nelson KH, López-Arnau R, Hempel BJ, To P, Manke HN, Crissman ME, Clasen MM, Rice KC, Riley AL.

Psychopharmacology (Berl). 2019 Mar;236(3):1067-1077. doi: 10.1007/s00213-018-5070-x. Epub 2018 Oct 17.

PMID:
30334086
22.

The abuse-related effects of pyrrolidine-containing cathinones are related to their potency and selectivity to inhibit the dopamine transporter.

Gannon BM, Baumann MH, Walther D, Jimenez-Morigosa C, Sulima A, Rice KC, Collins GT.

Neuropsychopharmacology. 2018 Nov;43(12):2399-2407. doi: 10.1038/s41386-018-0209-3. Epub 2018 Sep 10.

PMID:
30305739
23.

Behavioral economic analysis of the reinforcing effects of "bath salts" mixtures: studies with MDPV, methylone, and caffeine in male Sprague-Dawley rats.

Gannon BM, Mesmin MP, Sulima A, Rice KC, Collins GT.

Psychopharmacology (Berl). 2019 Mar;236(3):1031-1041. doi: 10.1007/s00213-018-5046-x. Epub 2018 Sep 29.

PMID:
30267131
24.

Extracellular esterase activity as an indicator of endoplasmic reticulum calcium depletion.

Trychta KA, Heathward EJ, Sulima A, Bäck S, Farokhnia M, Richie CT, Leggio L, Rice KC, Harvey BK.

Biomarkers. 2018 Dec;23(8):756-765. doi: 10.1080/1354750X.2018.1490968. Epub 2018 Aug 10.

PMID:
30095301
25.

Exercise Reverses Nociceptive Sensitization, Upregulated Neuropeptide Signaling, Inflammatory Changes, Anxiety, and Memory Impairment in a Mouse Tibia Fracture Model.

Shi X, Guo TZ, Li W, Sahbaie P, Rice KC, Sulima A, Clark JD, Kingery WS.

Anesthesiology. 2018 Sep;129(3):557-575. doi: 10.1097/ALN.0000000000002332.

PMID:
29994924
26.

Post-stroke Intranasal (+)-Naloxone Delivery Reduces Microglial Activation and Improves Behavioral Recovery from Ischemic Injury.

Anttila JE, Albert K, Wires ES, Mätlik K, Loram LC, Watkins LR, Rice KC, Wang Y, Harvey BK, Airavaara M.

eNeuro. 2018 Apr 18;5(2). pii: ENEURO.0395-17.2018. doi: 10.1523/ENEURO.0395-17.2018. eCollection 2018 Mar-Apr.

27.

The neurokinin-1 receptor mediates escalated alcohol intake induced by multiple drinking models.

Sequeira MK, Nelson BS, Fulenwider HD, King CE, Nennig SE, Bohannon JB, Cheng K, Rice KC, Heilig M, Schank JR.

Neuropharmacology. 2018 Jul 15;137:194-201. doi: 10.1016/j.neuropharm.2018.05.005. Epub 2018 May 3.

PMID:
29758386
28.

A rapid solution-based method for determining the affinity of heroin hapten-induced antibodies to heroin, its metabolites, and other opioids.

Torres OB, Duval AJ, Sulima A, Antoline JFG, Jacobson AE, Rice KC, Alving CR, Matyas GR.

Anal Bioanal Chem. 2018 Jun;410(16):3885-3903. doi: 10.1007/s00216-018-1060-4. Epub 2018 Apr 19.

29.

Delta/mu opioid receptor interactions in operant conditioning assays of pain-depressed responding and drug-induced rate suppression: assessment of therapeutic index in male Sprague Dawley rats.

Cone K, Lanpher J, Kinens A, Richard P, Couture S, Brackin R, Payne E, Harrington K, Rice KC, Stevenson GW.

Psychopharmacology (Berl). 2018 May;235(5):1609-1618. doi: 10.1007/s00213-018-4876-x. Epub 2018 Mar 23.

30.

Synthesis and activity of functionalizable derivatives of the serotonin (5-HT) 5-HT2A receptor (5-HT2AR) antagonist M100907.

Gilbertson SR, Chen YC, Soto CA, Yang Y, Rice KC, Cunningham KA, Anastasio NC.

Bioorg Med Chem Lett. 2018 May 1;28(8):1381-1385. doi: 10.1016/j.bmcl.2018.02.058. Epub 2018 Mar 16.

31.

Dissecting the Innate Immune Recognition of Opioid Inactive Isomer (+)-Naltrexone Derived Toll-like Receptor 4 (TLR4) Antagonists.

Zhang X, Cui F, Chen H, Zhang T, Yang K, Wang Y, Jiang Z, Rice KC, Watkins LR, Hutchinson MR, Li Y, Peng Y, Wang X.

J Chem Inf Model. 2018 Apr 23;58(4):816-825. doi: 10.1021/acs.jcim.7b00717. Epub 2018 Apr 11.

PMID:
29518316
32.

Comparative neuropharmacology of N-(2-methoxybenzyl)-2,5-dimethoxyphenethylamine (NBOMe) hallucinogens and their 2C counterparts in male rats.

Elmore JS, Decker AM, Sulima A, Rice KC, Partilla JS, Blough BE, Baumann MH.

Neuropharmacology. 2018 Nov;142:240-250. doi: 10.1016/j.neuropharm.2018.02.033. Epub 2018 Mar 1.

PMID:
29501528
33.

Cellular and behavioral effects of lipopolysaccharide treatment are dependent upon neurokinin-1 receptor activation.

Fulenwider HD, Smith BM, Nichenko AS, Carpenter JM, Nennig SE, Cheng K, Rice KC, Schank JR.

J Neuroinflammation. 2018 Feb 27;15(1):60. doi: 10.1186/s12974-018-1098-4.

34.

Corticotrophin releasing factor receptor 1 antagonists prevent chronic stress-induced behavioral changes and synapse loss in aged rats.

Dong H, Keegan JM, Hong E, Gallardo C, Montalvo-Ortiz J, Wang B, Rice KC, Csernansky J.

Psychoneuroendocrinology. 2018 Apr;90:92-101. doi: 10.1016/j.psyneuen.2018.02.013. Epub 2018 Feb 19.

35.

Application of Receptor Theory to the Design and Use of Fixed-Proportion Mu-Opioid Agonist and Antagonist Mixtures in Rhesus Monkeys.

Cornelissen JC, Obeng S, Rice KC, Zhang Y, Negus SS, Banks ML.

J Pharmacol Exp Ther. 2018 Apr;365(1):37-47. doi: 10.1124/jpet.117.246439. Epub 2018 Jan 12.

36.

Construction of Stable Fluorescent Reporter Plasmids for Use in Staphylococcus aureus.

Rodriguez MD, Paul Z, Wood CE, Rice KC, Triplett EW.

Front Microbiol. 2017 Dec 14;8:2491. doi: 10.3389/fmicb.2017.02491. eCollection 2017.

37.

Disease modifying actions of interleukin-6 blockade in a rat model of bone cancer pain.

Remeniuk B, King T, Sukhtankar D, Nippert A, Li N, Li F, Cheng K, Rice KC, Porreca F.

Pain. 2018 Apr;159(4):684-698. doi: 10.1097/j.pain.0000000000001139.

38.

Role of signalling molecules in behaviours mediated by the δ opioid receptor agonist SNC80.

Dripps IJ, Boyer BT, Neubig RR, Rice KC, Traynor JR, Jutkiewicz EM.

Br J Pharmacol. 2018 Mar;175(6):891-901. doi: 10.1111/bph.14131. Epub 2018 Feb 9.

39.

Heroin-HIV-1 (H2) vaccine: induction of dual immunologic effects with a heroin hapten-conjugate and an HIV-1 envelope V2 peptide with liposomal lipid A as an adjuvant.

Torres OB, Matyas GR, Rao M, Peachman KK, Jalah R, Beck Z, Michael NL, Rice KC, Jacobson AE, Alving CR.

NPJ Vaccines. 2017 May 2;2:13. doi: 10.1038/s41541-017-0013-9. eCollection 2017.

40.

Additive and subadditive antiallodynic interactions between μ-opioid agonists and N-methyl D-aspartate antagonists in male rhesus monkeys.

Cornelissen JC, Steele FF, Rice KC, Nicholson KL, Banks ML.

Behav Pharmacol. 2018 Feb;29(1):41-52. doi: 10.1097/FBP.0000000000000336.

41.

A Stable Heroin Analogue That Can Serve as a Vaccine Hapten to Induce Antibodies That Block the Effects of Heroin and Its Metabolites in Rodents and That Cross-React Immunologically with Related Drugs of Abuse.

Sulima A, Jalah R, Antoline JFG, Torres OB, Imler GH, Deschamps JR, Beck Z, Alving CR, Jacobson AE, Rice KC, Matyas GR.

J Med Chem. 2018 Jan 11;61(1):329-343. doi: 10.1021/acs.jmedchem.7b01427. Epub 2017 Dec 29.

42.

Inhibition of Cocaine and 3,4-Methylenedioxypyrovalerone (MDPV) Self-Administration by Lorcaserin Is Mediated by 5-HT2C Receptors in Rats.

Gannon BM, Sulima A, Rice KC, Collins GT.

J Pharmacol Exp Ther. 2018 Mar;364(2):359-366. doi: 10.1124/jpet.117.246082. Epub 2017 Dec 7.

43.

Novel Bivalent 5-HT2A Receptor Antagonists Exhibit High Affinity and Potency in Vitro and Efficacy in Vivo.

Soto CA, Shashack MJ, Fox RG, Bubar MJ, Rice KC, Watson CS, Cunningham KA, Gilbertson SR, Anastasio NC.

ACS Chem Neurosci. 2018 Mar 21;9(3):514-521. doi: 10.1021/acschemneuro.7b00309. Epub 2017 Nov 21.

44.

Antagonism of the kappa opioid receptor attenuates THC-induced place aversions in adult male Sprague-Dawley rats.

Clasen MM, Flax SM, Hempel BJ, Cheng K, Rice KC, Riley AL.

Pharmacol Biochem Behav. 2017 Dec;163:30-35. doi: 10.1016/j.pbb.2017.10.010. Epub 2017 Oct 31.

45.

Intermittent Access to Ethanol Induces Escalated Alcohol Consumption in Primates.

Lindell SG, Schwandt ML, Suomi SJ, Rice KC, Heilig M, Barr CS.

J Addict Behav Ther Rehabil. 2017 Apr;6(1). pii: 163. doi: 10.4172/2324-9005.1000163. Epub 2017 Apr 7.

46.

Remodeling of the Streptococcus mutans proteome in response to LrgAB and external stresses.

Ahn SJ, Gu T, Koh J, Rice KC.

Sci Rep. 2017 Oct 25;7(1):14063. doi: 10.1038/s41598-017-14324-w.

47.

Maintenance on naltrexone+amphetamine decreases cocaine-vs.-food choice in male rhesus monkeys.

Moerke MJ, Banks ML, Cheng K, Rice KC, Negus SS.

Drug Alcohol Depend. 2017 Dec 1;181:85-93. doi: 10.1016/j.drugalcdep.2017.09.020. Epub 2017 Oct 13.

48.

Antagonising TLR4-TRIF signalling before or after a low-dose alcohol binge during adolescence prevents alcohol drinking but not seeking behaviour in adulthood.

Jacobsen JHW, Buisman-Pijlman FT, Mustafa S, Rice KC, Hutchinson MR.

Neuropharmacology. 2018 Jan;128:460-473. doi: 10.1016/j.neuropharm.2017.09.028. Epub 2017 Sep 22.

PMID:
28947376
49.

Riverine discharges to Chesapeake Bay: Analysis of long-term (1927-2014) records and implications for future flows in the Chesapeake Bay basin.

Rice KC, Moyer DL, Mills AL.

J Environ Manage. 2017 Dec 15;204(Pt 1):246-254. doi: 10.1016/j.jenvman.2017.08.057. Epub 2017 Sep 6.

PMID:
28888206
50.

Role of monoaminergic systems and ambient temperature in bath salts constituent 3,4-methylenedioxypyrovalerone (MDPV)-elicited hyperthermia and locomotor stimulation in mice.

Gannon BM, Williamson A, Rice KC, Fantegrossi WE.

Neuropharmacology. 2018 May 15;134(Pt A):13-21. doi: 10.1016/j.neuropharm.2017.09.004. Epub 2017 Sep 5.

Supplemental Content

Support Center